对氯苯胺
对氯苯胺用途
用途2：氯苯胺可直接合成除虫脲，也可通过对氯苯基脲或对氯苯异氰酸酯来合成灭幼脲和除虫脲这两个品种，或通过2-氯-4-氨基苯酚来合成啶蜱脲，它还是除草剂莎稗磷和植物生长调节剂杀雄啉 (cintofen) 的中间体。此外，对氯苯胺也是染料、医药中间体，以及生产彩色电影胶片的成色剂。
用途3：氯苯胺是除草剂莎稗磷，杀虫剂灭幼脲和植物生长调节剂抗倒胺的中间体。
用途4：作偶氮染料及制造色酚AS-LB的中间体。也用作医药（如利眠宁、非那酊）、农药的中间体。还可用于生产彩色电影胶片的成色剂。目前，我国染料工业约消费对氯苯胺350t，其中色酚AS-LB约需对氯苯胺160t，有机颜料永固黄约60t、对氯吡唑酮约需80t。在医药工业中，利眠宁等药品产量每年在15-20t之间，生产这些药品约需对氯苯胺150t。1991年我国对氯苯胺出口量仅10t。
用途5：作染料中间体。
用途6：对氯苯胺用作偶氮染料及制造色酚AS-LB的中间体,也用作利眠宁,非那酊等医药中间体。
对氯苯胺名称
[ CAS 号 ]:
106-47-8
[ 中文名 ]:
对氯苯胺
[ 英文名 ]:
4-Chloroaniline
[中文别名 ]:
[英文别名 ]:
- Benzenamine,4-chloro
- p-Chloroaniline
- EINECS 203-401-0
- 4-Aminochlorobenzene
- 4-CHLORO ANILINE
- 1-Chloro-4-aminobenzene
- P-CHLORANILINE DS
- P-CHLORO-ANILINE
- para-Chloroaniline
- 4-Chloroaniline
对氯苯胺物理化学性质
[ 密度 ]:
1.2±0.1 g/cm3
[ 沸点 ]:
232.0±0.0 °C at 760 mmHg
[ 熔点 ]:
67-70 °C(lit.)
[ 分子式 ]:
C6H6ClN
[ 分子量 ]:
127.572
[ 闪点 ]:
89.5±19.8 °C
[ 精确质量 ]:
127.018875
[ PSA ]:
26.02000
[ LogP ]:
1.76
[ 外观性状 ]:
透明琥珀色液体
[ 蒸汽密度 ]:
4.4 (vs air)
[ 蒸汽压 ]:
0.1±0.4 mmHg at 25°C
[ 折射率 ]:
1.598
[ 储存条件 ]:
库房通风低温干燥,与氧化剂、食品添加剂分开存放
[ 稳定性 ]:
Stable. Combustible. Incompatible with strong oxidizing agents, acids, acid chlorides, acid anhydrides, chloroformates, nitrous acid. May be light sensitive.
[ 水溶解性 ]:
0.3 g/100 mL (20 ºC)
对氯苯胺MSDS
对氯苯胺毒性和生态
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- BX0700000
- CHEMICAL NAME :
- Aniline, p-chloro-
- CAS REGISTRY NUMBER :
- 106-47-8
- LAST UPDATED :
- 199712
- DATA ITEMS CITED :
- 45
- MOLECULAR FORMULA :
- C6-H6-Cl-N
- MOLECULAR WEIGHT :
- 127.58
- WISWESSER LINE NOTATION :
- ZR DG
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- Standard Draize test
- ROUTE OF EXPOSURE :
- Administration into the eye
- SPECIES OBSERVED :
- Rodent - rabbit
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 300 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Lungs, Thorax, or Respiration - respiratory depression
- TYPE OF TEST :
- LC50 - Lethal concentration, 50 percent kill
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 2340 mg/m3/4H
- TOXIC EFFECTS :
- Behavioral - somnolence (general depressed activity) Lungs, Thorax, or Respiration - dyspnea Lungs, Thorax, or Respiration - cyanosis
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 420 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LC12 - Lethal Concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 250 mg/m3/6H
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - dog
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Lungs, Thorax, or Respiration - other changes
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 239 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Mammal - cat
- DOSE/DURATION :
- 125 mg/kg
- TOXIC EFFECTS :
- Behavioral - altered sleep time (including change in righting reflex) Lungs, Thorax, or Respiration - respiratory depression Blood - other hemolysis with or without anemia
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Administration onto the skin
- SPECIES OBSERVED :
- Rodent - rabbit
- DOSE/DURATION :
- 360 mg/kg
- TOXIC EFFECTS :
- Skin and Appendages - primary irritation (after topical exposure)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - guinea pig
- DOSE/DURATION :
- 350 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - quail
- DOSE/DURATION :
- 237 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Bird - wild bird species
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3367 mg/kg/13W-I
- TOXIC EFFECTS :
- Blood - methemoglobinemia-carboxyhemoglobin Blood - changes in erythrocyte (RBC) count Kidney, Ureter, Bladder - other changes in urine composition
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 30 ug/m3/24H/80D-C
- TOXIC EFFECTS :
- Behavioral - muscle contraction or spasticity
- TYPE OF TEST :
- TCLo - Lowest published toxic concentration
- ROUTE OF EXPOSURE :
- Inhalation
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1 mg/m3/4H/17W-I
- TOXIC EFFECTS :
- Behavioral - aggression Blood - methemoglobinemia-carboxyhemoglobin Blood - changes in erythrocyte (RBC) count
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1 gm/kg/10D-I
- TOXIC EFFECTS :
- Blood - other changes
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 9270 mg/kg/2Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Endocrine - tumors
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 5150 mg/kg/2Y-C
- TOXIC EFFECTS :
- Tumorigenic - Carcinogenic by RTECS criteria Liver - tumors
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 14 gm/kg/78W-C
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Vascular - tumors Blood - tumors
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 18200 mg/kg/2Y-C
- TOXIC EFFECTS :
- Tumorigenic - neoplastic by RTECS criteria Blood - tumors
- TYPE OF TEST :
- TD - Toxic dose (other than lowest)
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 328 gm/kg/78W-C
- TOXIC EFFECTS :
- Tumorigenic - equivocal tumorigenic agent by RTECS criteria Vascular - tumors
MUTATION DATA
- TYPE OF TEST :
- Morphological transformation
- TEST SYSTEM :
- Rodent - hamster Embryo
- DOSE/DURATION :
- 10 ug/L
- REFERENCE :
- NCIMAV National Cancer Institute, Monograph. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) No.1- 1959- Volume(issue)/page/year: 58,243,1981 *** REVIEWS *** IARC Cancer Review:Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 57,305,1993 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 57,305,1993 IARC Cancer Review:Group 2B IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 57,305,1993
对氯苯胺安全信息
[ 符号 ]:
GHS06, GHS08, GHS09
[ 信号词 ]:
Danger
[ 危害声明 ]:
H301 + H311 + H331-H317-H350-H410
[ 警示性声明 ]:
P201-P261-P280-P301 + P310 + P330-P308 + P313-P403 + P233
[ 个人防护装备 ]:
Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
[ 危害码 (欧洲) ]:
T:Toxic
[ 风险声明 (欧洲) ]:
R23/24/25;R43;R45;R50/53
[ 安全声明 (欧洲) ]:
S53-S45-S60-S61-S36/37-S16-S7
[ 危险品运输编码 ]:
UN 2018 6.1/PG 2
[ WGK德国 ]:
3
[ RTECS号 ]:
BX0700000
[ 包装等级 ]:
II
[ 危险类别 ]:
6.1
[ 海关编码 ]:
2921420090
对氯苯胺合成路线
对氯苯胺上下游产品
对氯苯胺上游产品
对氯苯胺下游产品
对氯苯胺制备
其制备方法是对硝基氯苯进行还原得到对氯苯胺，有铁粉还原、加氢还原和锌粉还原等几种方法。
铁粉还原法：
将对氯硝基苯、水和铁屑混合并加热至 95℃，对氯硝基苯完全溶化后滴加浓盐酸，调节滴加速度，使温度保持在25℃，滴加完毕后继续反应25h，冷却，加入过量氢氧化钠，使溶液呈碱性，蒸馏油层即得产品。
加氢还原法：
将对氯硝基苯和乙醇按质量比1∶1.5混合，加入兰尼镍 (由100目镍铝二元合金制得)作催化剂，于温度为 50～70℃、压力 2.94～3.43 MPa、介质 pH=5～6 的条件下，通氢气反应 2h，所得粗品在常压下蒸出乙醇和部分水，再减压蒸馏即得成品。
此外，也有将对氯硝基苯与锌粉在乙酸介质中进行还原，可以较高收率得到对氯苯胺，但锌粉价格较高。
对氯苯胺海关
[ 海关编码 ]: 2921420090
[ 中文概述 ]:
2921420090 其他苯胺衍生物及其盐. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0%
[ 申报要素 ]: 品名, 成分含量, 用途
[ Summary ]:
HS:2921420090 aniline derivatives and their salts VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%
对氯苯胺文献
Eur. J. Pharm. Sci. 63 , 14-21, (2014)
A capillary isoelectric focusing (cIEF) method was developed for the determination of the ionization constants (pKa) of small molecules. Two approaches used to decrease the electroosmotic flow (EOF) w...
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).J. Med. Chem. 48 , 3269-79, (2005)
Growing interest in the use of both the logarithm of the partition coefficient of the neutral species in the alkane/water system (log P(N)(alk)) and the difference between log P(N)(oct) (the logarithm...
Synthesis and application of hybrid polymer composites based on silver nanoparticles as corrosion protection for line pipe steel.Molecules 19(5) , 6246-62, (2014)
A facile method was developed to synthesize in high yield dispersed silver nanoparticles (AgNPs) with small particle sizes of less than 10 nm. Silver nitrate was reduced to silver nanoparticles by p-c...
相关化工产品/化学物质：
推荐生产厂家/供应商：
公司名：上海化源世纪贸易有限公司
区域：上海市普陀区
价格：
联系人：徐经理
产品详情：对氯苯胺
公司名：上海吉至生化科技有限公司
区域：上海市奉贤区
价格：
￥138.0/500g
联系人：刘佳
产品详情：对氯苯胺
公司名：上海阿拉丁生化科技股份有限公司
区域：上海市浦东新区
价格：
￥169.0/1g
￥需询单/1g
￥需询单/1g
￥需询单/1g
联系人：阿拉丁
产品详情：对氯苯胺
公司名：廊坊乾耀科技有限公司
区域：廊坊市大城县
价格：
￥需询单/500g
￥需询单/25kg
￥需询单/1ton
联系人：李菊青
产品详情：对氯苯胺
查看所有供应商请点击：
相关化合物
【对氯苯胺】化源网提供对氯苯胺CAS号106-47-8，对氯苯胺MSDS及其说明、性质、英文名、生产厂家、作用/用途、分子量、密度、沸点、熔点、结构式等。CAS号查询对氯苯胺上化源网，专业又轻松。>>电脑版：对氯苯胺
标题：对氯苯胺_MSDS_用途_密度_对氯苯胺CAS号【106-47-8】_化源网 地址：https://m.chemsrc.com/mip/cas/106-47-8_895921.html